News
A judge intends to rule this week on a plan for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids.
A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids.
All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind ...
Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, ...
The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 ...
Nebraska could see as much as $19.7 million from the settlement if it moves forward, according to Attorney General Mike Hilger's office.
Arkansas’ portion of the recent $7.4 billion settlement with Purdue Pharma and the Sackler family for their role in the ...
A proposed $7.4B settlement, which still needs court approval, would resolve states' litigation against makers and marketers of opioid OxyContin.
A new $7.4 billion opioid settlement for Purdue Pharma and the Sackler family has been approved by all U.S. states and territories ...
Iowa is signing on to a $7.4 billion national settlement with Purdue Pharma and its owners, the Sackler family, over their ...
Iowa will receive $37.8 million in opioid settlement funds after the state signed onto a settlement agreement with OxyContin ...
Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results